BG65954B1 - Средство за селективно подтискане активността на патологични автореактивни в-клетки - Google Patents

Средство за селективно подтискане активността на патологични автореактивни в-клетки Download PDF

Info

Publication number
BG65954B1
BG65954B1 BG109003A BG10900305A BG65954B1 BG 65954 B1 BG65954 B1 BG 65954B1 BG 109003 A BG109003 A BG 109003A BG 10900305 A BG10900305 A BG 10900305A BG 65954 B1 BG65954 B1 BG 65954B1
Authority
BG
Bulgaria
Prior art keywords
cells
pathologic
autoreactive
activity
immunoglobulin
Prior art date
Application number
BG109003A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG109003A (en
Inventor
Чавдар ВАСИЛЕВ
Андрей ЧОРБАНОВ
Original Assignee
Чавдар ВАСИЛЕВ
Андрей ЧОРБАНОВ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чавдар ВАСИЛЕВ, Андрей ЧОРБАНОВ filed Critical Чавдар ВАСИЛЕВ
Priority to BG109003A priority Critical patent/BG65954B1/bg
Priority to PCT/BG2006/000001 priority patent/WO2006072152A2/fr
Priority to EP06703172A priority patent/EP1844075A2/fr
Publication of BG109003A publication Critical patent/BG109003A/en
Publication of BG65954B1 publication Critical patent/BG65954B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG109003A 2005-01-05 2005-01-05 Средство за селективно подтискане активността на патологични автореактивни в-клетки BG65954B1 (bg)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BG109003A BG65954B1 (bg) 2005-01-05 2005-01-05 Средство за селективно подтискане активността на патологични автореактивни в-клетки
PCT/BG2006/000001 WO2006072152A2 (fr) 2005-01-05 2006-01-04 Suppresseur de lymphocytes b autoreactifs associes a des maladies
EP06703172A EP1844075A2 (fr) 2005-01-05 2006-01-04 Suppresseur de lymphocytes b autoreactifs associes a des maladies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG109003A BG65954B1 (bg) 2005-01-05 2005-01-05 Средство за селективно подтискане активността на патологични автореактивни в-клетки

Publications (2)

Publication Number Publication Date
BG109003A BG109003A (en) 2006-07-31
BG65954B1 true BG65954B1 (bg) 2010-07-30

Family

ID=36647833

Family Applications (1)

Application Number Title Priority Date Filing Date
BG109003A BG65954B1 (bg) 2005-01-05 2005-01-05 Средство за селективно подтискане активността на патологични автореактивни в-клетки

Country Status (3)

Country Link
EP (1) EP1844075A2 (fr)
BG (1) BG65954B1 (fr)
WO (1) WO2006072152A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA035419B9 (ru) 2014-05-29 2020-08-07 Мэкроудженикс, Инк. Триспецифичные связывающие молекулы и способы их применения
BR112018006817A2 (pt) 2015-10-08 2018-10-23 Macrogenics Inc método de tratamento do câncer
US20200048321A1 (en) * 2017-03-24 2020-02-13 Orpheus Bioscience Inc. Pantids for treatment of autoimmune disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG108155A (en) * 2003-09-04 2005-06-30 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516760D0 (en) * 1995-08-16 1995-10-18 Sandoz Ltd Organic compounds
US6001964A (en) * 1995-09-20 1999-12-14 Albert Einstein College Of Medicine Of Yeshiva University Peptides which bind to anti-double stranded DNA antibody
US7118743B2 (en) * 1998-11-17 2006-10-10 Tanox, Inc. Bispecific molecules cross-linking ITIM and ITAM for therapy
CA2462883A1 (fr) * 2001-10-12 2003-04-17 Schering Corporation Utilisation d'anticorps bispecifiques pour reguler des reponses immunitaires

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG108155A (en) * 2003-09-04 2005-06-30 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells

Also Published As

Publication number Publication date
BG109003A (en) 2006-07-31
EP1844075A2 (fr) 2007-10-17
WO2006072152A2 (fr) 2006-07-13
WO2006072152A3 (fr) 2008-12-24

Similar Documents

Publication Publication Date Title
RU2047177C1 (ru) Способ определения b-лимфоцитов, продуцирующих ige
Yamada et al. Human inositol 1, 4, 5-trisphosphate type-1 receptor, Ins P 3R1: Structure, function, regulation of expression and chromosomal localization
ES2240981T3 (es) Citocina denominada lerk-7.
CN101506235B (zh) 人或人源化免疫球蛋白在非人转基因动物中增强的表达
Miletic et al. Complement—immunoglobulin interactions
Termaat et al. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms
Reichlin Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins
JP6538707B2 (ja) 免疫応答を調節するための方法及び組成物
ES2271004T3 (es) Uso de taci como agente antitumoral.
Zone et al. IgA autoimmune disorders: development of a passive transfer mouse model
EA009026B1 (ru) Антитела против il-22ra, их партнеры по связыванию и способы их применения при воспалениях
JPH02238892A (ja) ウイルスの感染性を阻止するヒトライノウイルス受容体タンパク質
EA015351B1 (ru) Антагонисты il-17a и il-17f и способы их применения
JPH03501927A (ja) ＩｇＥ産出性Ｂリンパ球上の独特な抗原決定基
JP2000507816A (ja) 増大した半減期を有する免疫グロブリン様ドメイン
JPH05507197A (ja) 結合部位を含む可溶性ペプチド類縁体
Hale Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein
EA015706B1 (ru) Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела
Zhang et al. Targeting of functional antibody-CD59 fusion proteins to a cell surface
WO1995003827A1 (fr) Procede de traitement de la sclerose en plaques
JP2021521817A5 (fr)
Kleppel et al. Immunochemical studies of the Alport antigen
JPH06501837A (ja) メラノーマに対する腫瘍ワクチンとしてのｇｐ７５
Morioka et al. Histone mediates glomerular deposition of small size DNA anti-DNA complex
JPH07509776A (ja) Ｂ型肝炎ウイルス受容体活性を有するエンドネキシン■由来ポリペプチド，並びに診断および製剤組成物におけるその用途